AmerisourceBergen Completes Canadian Distribution Sale


The world's largest pharmaceuticals distributor, AmerisourceBergen , has completed the divestiture of its Canadian distribution business to Kohl & Frisch Limited, the country's only Canadian-owned national full-line pharmaceutical distributor, AmerisourceBergen announced yesterday.

AmerisourceBergen had expected the sale price to be between $80 million and $100 million when it announced the deal at the end of March, though no final tally was provided in yesterday's press release. It recorded estimated losses on sale of the business, as well as other impairment charges, of $161.7 million, the low end of the range it initially gave of $160 million to $180 million. However there could be post-closing price adjustments, which are expected to be finalized during the quarter ending Sept. 30.

The Canadian distribution business represented some 2% of ABC's total revenues. Moving the business to discontinued operations allowed the pharmaceuticals distributor to increase its estimated earnings per share from continuing operations for 2013 from $2.96 to $3.06, to $3.04 to $3.14. It continues to expect free cash flow in the range of $100 million to $200 million, and to repurchase approximately $400 million of common stock in fiscal 2013.

Headquartered in Valley Forge, Pa., AmerisourceBergen has more than $80 billion in annualized revenue.


The article AmerisourceBergen Completes Canadian Distribution Sale originally appeared on

Fool contributor Rich Duprey has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Originally published